Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism

  • Technology appraisal guidance
  • TA354
  • Published: 
Download (PDF)

What has NICE said?

Edoxaban (Lixiana) is recommended as an option for treating and preventing recurrent deep vein thrombosis or pulmonary embolism.

What does this mean for me?

If you have deep vein thrombosis or pulmonary embolism and your doctor thinks that edoxaban is the right treatment, you should be able to have the treatment on the NHS.

Edoxaban should be available on the NHS within 3 months of the guidance being issued.

  • Information Standard

This page was last updated: